Danaher
Danaher Corporation is an American global life sciences and diagnostics innovator that designs, manufactures, and markets professional, medical, and commercial products. The company structures its operational business activities across three primary reportable segments: Biotechnology, Life Sciences, and Diagnostics. Its technical product lineup includes flow cytometers, mass spectrometers, centrifuge equipment, molecular diagnostic testing kits, and bioprocess filtration equipment under brands like Cytiva, Beckman Coulter, and Cepheid. Principal revenue drivers consist of high-margin recurring sales of diagnostic test cartridges, bioprocessing consumables, laboratory reagents, and analytical instrumentation hardware. Danaher serves broad global healthcare and research end markets comprising biopharmaceutical companies, academic research universities, clinical diagnostic laboratories, and hospital networks worldwide. The enterprise holds a dominant global market position as a premier supplier of bioprocessing tools and automated diagnostic testing infrastructure. Headquartered in Washington, D.C., the company's common stock is publicly traded on the New York Stock Exchange under the ticker symbol DHR and is included in the S&P 500 index.
73 of the funds FundTelligence covers report a position in Danaher.
- Legal name
- Danaher Corp.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 73
Funds holding Danaher
- Kavaljer Investmentbolagsfond — Kavaljer · 6.0 % (partially disclosed portfolio, October 2026)
- Spiltan Globalfond Investmentbolag — Spiltan Fonder · 5.91 % (full portfolio disclosed, June 2026)
- Polar Capital Global Healthcare Select Fund — Polar Capital · 3.8 % (largest positions only, October 2026)
- Franklin Sustainable Global Growth Fund — Franklin Templeton · 3.56 % (full portfolio disclosed, September 2026)
- GS Liquid Euro — Goldman Sachs · 3.14 % (largest positions only, March 2026)
- Nordea Global Portfolio Fund — Nordea Funds · 3.01 % (full portfolio disclosed, September 2026)
- Nordea PM Globale Aktier Fokus — Nordea Funds · 2.97 % (full portfolio disclosed, September 2026)
- Fidelity Global Focus Fund — Fidelity · 2.7 % (largest positions only, October 2026)
Showing the 8 largest of 73 funds holding it.